409 related articles for article (PubMed ID: 16361982)
1. Bisphosphonate treatment of pediatric bone disease.
Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
[TBL] [Abstract][Full Text] [Related]
2. Alternative indications for bisphosphonate therapy.
Landesberg R; Eisig S; Fennoy I; Siris E
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
[TBL] [Abstract][Full Text] [Related]
3. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.
Simm PJ; Biggin A; Zacharin MR; Rodda CP; Tham E; Siafarikas A; Jefferies C; Hofman PL; Jensen DE; Woodhead H; Brown J; Wheeler BJ; Brookes D; Lafferty A; Munns CF;
J Paediatr Child Health; 2018 Mar; 54(3):223-233. PubMed ID: 29504223
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
Toussaint ND; Elder GJ; Kerr PG
Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
[TBL] [Abstract][Full Text] [Related]
6. Alendronate treatment in children with osteogenesis imperfecta.
Akcay T; Turan S; Guran T; Bereket A
Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.
Löwing K; Aström E; Oscarsson KA; Söderhäll S; Eliasson AC
Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486
[TBL] [Abstract][Full Text] [Related]
8. Experience with bisphosphonates in osteogenesis imperfecta.
Glorieux FH
Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of osteogenesis imperfecta with bisphosphonates].
Tau C
Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
[TBL] [Abstract][Full Text] [Related]
10. Prolonged bisphosphonate release after treatment in children.
Papapoulos SE; Cremers SC
N Engl J Med; 2007 Mar; 356(10):1075-6. PubMed ID: 17347467
[No Abstract] [Full Text] [Related]
11. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
Schwartz S; Joseph C; Iera D; Vu DD
J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
[TBL] [Abstract][Full Text] [Related]
12. Osteogenesis imperfecta, current and future medical treatment.
Rauch F; Glorieux FH
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):31-7. PubMed ID: 16278881
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
Drake MT; Cremers SC
Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
[TBL] [Abstract][Full Text] [Related]
14. Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy.
D'Eufemia P; Finocchiaro R; Zambrano A; Tetti M; Ferrucci V; Celli M
Biomed Pharmacother; 2007 May; 61(4):235-40. PubMed ID: 17275249
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate use in conditions other than osteoporosis.
Silverman SL
Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575
[TBL] [Abstract][Full Text] [Related]
16. Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
Smith EJ; Little DG; Briody JN; McEvoy A; Smith NC; Eisman JA; Gardiner EM
J Bone Miner Res; 2005 Oct; 20(10):1731-41. PubMed ID: 16160731
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
18. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta.
Kamoun-Goldrat A; Ginisty D; Le Merrer M
Eur J Oral Sci; 2008 Jun; 116(3):195-8. PubMed ID: 18471236
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
20. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]